🔴 Tenax Therapeutics is trading 5.3% down today as Nasdaq Composite falls 1.33%

Tenax Therapeutics is trading 5.3% down now at $1.62 amid broader market weakness.

• The Nasdaq Composite is down 1.33%, while the S&P 500 is down 0.60%.
• No new company-specific announcement was identified for August 18, 2026.
• Sentiment remains fragile after the August 10 Phase 3 LEVEL trial failure, which sent shares down nearly 90%; trading remains highly volatile after recent sharp price swings, and that catalyst is not new today.